Harrow, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Harrow, Inc. stock issued during period, value, issued for services for the quarter ending 2013-12-31 was -$180.34K.
- Harrow, Inc. stock issued during period, value, issued for services for the quarter ending 2013-09-30 was $180.34K.
- Harrow, Inc. stock issued during period, value, issued for services for fiscal 2016 was $302.00K.
- Harrow, Inc. stock issued during period, value, issued for services for fiscal 2013 was $139.44K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2016-12-31 | $302.00K 10-K · filed 2018-03-08 | |
| 2013-12-31 | -$180.34K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $139.44K 10-K · filed 2015-03-12 |
| 2013-09-30 | $180.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |